CSF2 and rheumatoid arthritis: Among the downstream effector cytokines of this pathway, GM-CSF has been shown to contribute to the pathogenesis of other inflammatory diseases and is targeted in new therapeutic strategies for neuroinflammation [22] and rheumatoid arthritis [10, 11].